LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to:

1. Apply NCCN guidelines and other evidence-based standards when developing treatment plans for thoracic cancer patients.

2. Identify optimal timing for surgical intervention in patients with metastatic disease to improve outcomes.

3. Integrate emerging treatment modalities and clinical trial options into multidisciplinary care planning for complex cases.

4. Collaborate effectively within a multidisciplinary team to formulate comprehensive, patient-centered treatment strategies.

PLANNER/MODERATOR DISCLOSURE: The planners have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC: Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

For information, please contact Christopher Bremer at [email protected]

This activity indicates that physicians will gain knowledge on the best way to treat the specifics patients’ care using the NCCN guidelines. All the physicians will agree on the best treatment options and be able to communicate the same treatment option to the patients.